Vietnam MOH registration 2402950ĐKLH/BYT-HTTB

Drug test, qualitative antibody test for IgG and IgM against HBcAg

VN: Thuốc thử, chất hiệu chuẩn xét nghiệm định tính kháng thể IgG và IgM kháng HBcAg
Vietnam flagVietnam·Risk Class TTBYT Loại D·Theo theo phụ lục·Registered Oct 22, 2024
Registration details
Analysis ID
2402950ĐKLH/BYT-HTTB
Submission ID
000.00.04.G18-230823-0015
Product Type
Theo theo phụ lục
Product Code
Theo phụ lục
Company information
Authorized Representative
CÔNG TY TNHH ROCHE VIỆT NAM
Technical details
Intended Use
In vitro immunoassay for the qualitative determination of IgG and IgM antibodies against the core antigen of the hepatitis B virus in human serum and plasma. The "ECLIA" (electrochemiluminescence immunoassay "ECLIA") is used for the cobas e immunoassay analyzers.
Dates and status
Registration Date
Oct 22, 2024
Companies making similar products

Companies providing products similar to "Drug test, qualitative antibody test for IgG and IgM against HBcAg"

Recent registrations

Recently registered similar products

About this record

Access comprehensive regulatory information for Drug test, qualitative antibody test for IgG and IgM against HBcAg in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại D medical device is registered under number 2402950ĐKLH/BYT-HTTB. The authorized representative in Vietnam is CÔNG TY TNHH ROCHE VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details, 1 companies making similar products including Roche Diagnostics GmbH, and 1 recent registrations in the same category. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free DatabasePowered by Pure Global AI300,000+ Devices1 Competitors1 Recent Registrations